Relationship between PTEN gene expression and differentiation of human glioma
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Standard
Relationship between PTEN gene expression and differentiation of human glioma. / Yang, Y.; Shao, N.; Luo, G.; Li, L.; Nilsson-Ehle, Peter; Xu, Ning.
I: Scandinavian Journal of Clinical & Laboratory Investigation, Vol. 66, Nr. 6, 2006, s. 469-475.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Harvard
APA
CBE
MLA
Vancouver
Author
RIS
TY - JOUR
T1 - Relationship between PTEN gene expression and differentiation of human glioma
AU - Yang, Y.
AU - Shao, N.
AU - Luo, G.
AU - Li, L.
AU - Nilsson-Ehle, Peter
AU - Xu, Ning
PY - 2006
Y1 - 2006
N2 - Objective. To investigate the relationship between PTEN gene expression and differentiation of glioma. Material and methods. The quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) method was applied to detect PTEN mRNA levels in glioma tissues. Tumor-adjacent normal tissues and benign brain tumors were used as controls. Relative PTEN mRNA levels were determined as the ratio of PTEN and GAPDH, which were correlated with the clinical pathological results. Results. PTEN mRNA levels were significantly lower in the glioma tissues than in the benign brain tumors and tumor-adjacent normal tissues, whereas there were no statistical differences between benign brain tumor and the tumor-adjacent normal tissues. According to the pathological examinations, PTEN mRNA levels were higher in the high differential glioma than the low differential glioma. Conclusions. PTEN gene expression was suppressed in the glioma, which is related to the clinical-pathological results. It is suggested that determination of PTEN mRNA levels by RT-PCR could be a novel marker of disease classification.
AB - Objective. To investigate the relationship between PTEN gene expression and differentiation of glioma. Material and methods. The quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) method was applied to detect PTEN mRNA levels in glioma tissues. Tumor-adjacent normal tissues and benign brain tumors were used as controls. Relative PTEN mRNA levels were determined as the ratio of PTEN and GAPDH, which were correlated with the clinical pathological results. Results. PTEN mRNA levels were significantly lower in the glioma tissues than in the benign brain tumors and tumor-adjacent normal tissues, whereas there were no statistical differences between benign brain tumor and the tumor-adjacent normal tissues. According to the pathological examinations, PTEN mRNA levels were higher in the high differential glioma than the low differential glioma. Conclusions. PTEN gene expression was suppressed in the glioma, which is related to the clinical-pathological results. It is suggested that determination of PTEN mRNA levels by RT-PCR could be a novel marker of disease classification.
KW - RT
KW - glioma
KW - PTEN
KW - PCR
U2 - 10.1080/00365510600763285
DO - 10.1080/00365510600763285
M3 - Article
VL - 66
SP - 469
EP - 475
JO - Scandinavian Journal of Clinical & Laboratory Investigation
JF - Scandinavian Journal of Clinical & Laboratory Investigation
SN - 1502-7686
IS - 6
ER -